ZIOPHARM Oncology, Inc. Announces Third Quarter Financial Results and Key Developments

November 9, 2012 |

1 min read

NEW YORK, Nov. 8, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the third quarter ended September 30, 2012, and provided an update on the Company's key development activities.

Earnings

MORE ON THIS TOPIC

Piggy bank rocket launcher with smoke trail on blue background. Savings growth concept. 3D Rendering, 3D Illustration

Alzheimer’s disease

Korsana Joins Alzheimer’s Amyloid Arena With $150M Debut, Next-Gen Antibody

February 18, 2026

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Concerto Downsizes Amid Pivot to Consumers; Faraday Closes Down

February 18, 2026

·

55 min read

·

BioSpace Editorial Staff

Podcast

Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders

February 18, 2026

·

1 min read

·

Heather McKenzie

Pictured: Gavel hitting pill bottles with abstract money background

Patents

Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors

February 18, 2026

·

4 min read

·

Shawna Williams